Do non-antiarrhythmic drugs have enough pleiotropic power to reduce atrial fibrillation?

Editorial

Richard J Folkeringa et al. Europace. 2010 Mar.

. 2010 Mar;12(3):299-300.

doi: 10.1093/europace/euq009.

No abstract available

Comment on

The impact of statins and renin-angiotensin-aldosterone system blockers on pulmonary vein antrum isolation outcomes in post-menopausal females.
Patel D, Mohanty P, Di Biase L, Wang Y, Shaheen MH, Sanchez JE, Horton RP, Gallinghouse GJ, Zagrodzky JD, Bailey SM, Burkhardt JD, Lewis WR, Diaz A, Beheiry S, Hongo R, Al-Ahmad A, Wang P, Schweikert R, Natale A. Patel D, et al. Europace. 2010 Mar;12(3):322-30. doi: 10.1093/europace/eup387. Epub 2010 Jan 10. Europace. 2010. PMID: 20064822 Clinical Trial.

Class 1 antiarrhythmic agents for therapy of atrial fibrillation.
Podrid PJ. Podrid PJ. Herz. 1993 Feb;18(1):9-19. Herz. 1993. PMID: 8454255 Review.
[Antiarrhythmic drugs in atrial fibrillation].
Brembilla-Perrot B. Brembilla-Perrot B. Rev Prat. 2002 Jun 15;52(12):1317-23. Rev Prat. 2002. PMID: 12187895 Review. French.
Electropharmacological effects of antiarrhythmic drugs on atrial fibrillation termination. Part II: New insights into the electrophysiological mechanisms of atrial fibrillation termination.
Calò L, Sciarra L, Lamberti F, Loricchio ML, Castro A, Bianconi L, Pandozi C, Gaita F, Santini M. Calò L, et al. Ital Heart J. 2003 Jul;4(7):442-7. Ital Heart J. 2003. PMID: 14558294
The risk of antiarrhythmic drugs in atrial fibrillation: 20 years of controversies.
Le Heuzey JY. Le Heuzey JY. Europace. 2009 Jul;11(7):840-1. doi: 10.1093/europace/eup175. Europace. 2009. PMID: 19546183 No abstract available.
Risk of proarrhythmic events in the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study: a multivariate analysis.
Kaufman ES, Zimmermann PA, Wang T, Dennish GW 3rd, Barrell PD, Chandler ML, Greene HL; Atrial Fibrillation Follow-up Investigation of Rhythm Management investigators. Kaufman ES, et al. J Am Coll Cardiol. 2004 Sep 15;44(6):1276-82. doi: 10.1016/j.jacc.2004.06.052. J Am Coll Cardiol. 2004. PMID: 15364332 Clinical Trial.